1. Get the Diabetes Forum App for your phone - available on iOS and Android.
    Dismiss Notice
  2. Guest, we'd love to know what you think about the forum! Take the Diabetes Forum Survey 2021 »
    Dismiss Notice
  3. Diabetes Forum should not be used in an emergency and does not replace your healthcare professional relationship. Posts can be seen by the public.
    Dismiss Notice
  4. Guest, stay home, stay safe, save the NHS. Stay up to date with information about keeping yourself and people around you safe here and GOV.UK: Coronavirus (COVID-19). Think you have symptoms? NHS 111 service is available here.
    Dismiss Notice
Dismiss Notice
Find support, ask questions and share your experiences. Join the community »

Byetta LAR.

Discussion in 'Diabetes Discussions' started by catherinecherub, Jan 29, 2010.

  1. catherinecherub

    catherinecherub · Guest

    A "Gold standard" of Byetta, named Byetta LAR will be available in 2013 according to analysts.

    It will be a once weekly injection as opposed to the current twice a day.

    20% of suitable Diabetics will be offered this treatment in Europe, due to costs and 40% would be a likely percentage in USA according to Endo forcasts.

    http://www.medicalnewstoday.com/articles/177207.php
     
  2. humph

    humph · Well-Known Member

    Messages:
    95
    Likes Received:
    0
    Trophy Points:
    26
    Byetta LAR is due to get US approval early next month and should get European approval later in the year.

    Though it appears that it will get a new name at launch, though Lily haven't ruled out keeping the name, but suggest it is unlikely.
     
  3. Patch

    Patch Type 2 · Well-Known Member

    Messages:
    2,981
    Likes Received:
    158
    Trophy Points:
    103
    My god. A once weekly injection? That is awesome.
     
  4. cugila

    cugila · Master

    Messages:
    10,272
    Likes Received:
    98
    Trophy Points:
    118
    Humph.
    Do you have a source for that information. I would be interested to see that.

    According to the info on the Stock Market (US) Amylin expects to file for regulatory approval of once weekly Byetta by the end of the second quarter. That is only the first step in getting approval for the issuing of the drug, that could take quite some time as it is a long winded process.

    So I wouldn't bank on it being available anytime soon.....!

    Ken.
     
  5. humph

    humph · Well-Known Member

    Messages:
    95
    Likes Received:
    0
    Trophy Points:
    26
    http://online.wsj.com/article/BT-CO-20100126-709340.html

    This link states that it is expected March, but some expect delays. I am on a drugs sales rep forum and they are confident they will get approval. I did also find a link were someone from the company said they were confident, but cannot find it at the moment.

    The FDA won't want Novo Nordisk getting to great a time advantage over an American product.


    http://industry.bnet.com/pharma/100...on-the-byetta-name-for-exenatide-once-weekly/

    This article is about the possible name change.
     
  6. humph

    humph · Well-Known Member

    Messages:
    95
    Likes Received:
    0
    Trophy Points:
    26
  7. cugila

    cugila · Master

    Messages:
    10,272
    Likes Received:
    98
    Trophy Points:
    118
    Hi Humph.
    Thanks for those links, I had seen a couple of them before, unfortunately they are all US info about the drug.

    We do not as yet have anything about a UK licence, which first of all has to go through the EMEA, the European Medical Agency. They are the ones who will licence it here and in Europe. Not the FDA.

    Do you have anything that actually relates to the release in Europe and more importantly the UK ? We are usually around 12 - 18 months behind what takes place in the States. :(

    Ken.
     
  8. humph

    humph · Well-Known Member

    Messages:
    95
    Likes Received:
    0
    Trophy Points:
    26
    Byetta LAR or as it is now called Bydureon didn't get FDA approval, but the issues raised were mainly to do with labeling. It looks like no issue with thyroid cancer was raised, unlike the black box labeling requirement with Liraglutide. The FDA have not requested any additional clinical trials.

    Approval is now expected within 10 weeks. My Consultant reckons approval here will be quicker than normal because Bydureon is likely to be cheaper than Victoza. Byetta is already cheaper.

    Who knows, but Bydureon will likely be a very good addition to the drugs available.
     
  • Meet the Community

    Find support, connect with others, ask questions and share your experiences with people with diabetes, their carers and family.

    Did you know: 7 out of 10 people improve their understanding of diabetes within 6 months of being a Diabetes Forum member. Get the Diabetes Forum App and stay connected on iOS and Android

    Grab the app!
  • Tweet with us

  • Like us on Facebook